Vismodegib for Treatment of Basal Cell Carcinoma

Summary

The primary objectives of this study are to assess, using Mohs micrographic surgery (MMS) at the end of treatment, the efficacy (primary) and safety (secondary) of vismodegib compared to placebo in the oral adjunctive pre surgical treatment of basal cell carcinoma. A secondary objective is to assess how often and in what types of lesions does pre surgical treatment with vismodegib result in complete eradication of the tumor.

Timeline

Start

2012-05

Primary completion

2013-06

Completion

2013-07

Drugs

Indications